US MFN drug pricing may not have immediate impact on Indian pharma firms (Soban News)

Analysts say the US move to link drug prices to the lowest global benchmarks targets patented medicines, limiting near-term risks for India’s largely generic-focused exporters​Analysts say the US move to link drug prices to the lowest global benchmarks targets patented medicines, limiting near-term risks for India’s largely generic-focused exporters ​Latest News [ SOBAN NEWS: International and National ]